Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries

J Infect Dis. 2023 Aug 16;228(4):368-370. doi: 10.1093/infdis/jiad026.

Abstract

Fewer than half of the world's infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.

Keywords: Hepatitis B; global health equity; prevention of mother-to-child transmission; vaccination.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Developing Countries
  • Female
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines
  • Hepatitis B virus
  • Hepatitis B* / prevention & control
  • Humans
  • Infant
  • Infectious Disease Transmission, Vertical / prevention & control
  • Liver Neoplasms*
  • Pregnancy
  • Pregnancy Complications, Infectious*

Substances

  • Hepatitis B Vaccines
  • Hepatitis B Surface Antigens